Xijia Feng

机构：Shanghai Jiao Tong University, Ruijin Hospital · ORCID：0000-0001-9952-0425

发表论文 18 篇 · 总被引 456 次 · h-index 8

代表论文

• Preoperative pembrolizumab combined with chemoradiotherapy for oesophageal squamous cell carcinoma (PALACE-1) (2020 · European Journal of Cancer · 被引 326)
• Treatments for resectable esophageal cancer: from traditional systemic therapy to immunotherapy (2022 · Chinese Medical Journal · 被引 30)
• COVID-19 and early-stage lung cancer both featuring ground-glass opacities: a propensity score-matched study (2020 · Translational Lung Cancer Research · 被引 27)
• Anti-tumor effects of dual PI3K-HDAC inhibitor CUDC-907 on activation of ROS-IRE1α-JNK-mediated cytotoxic autophagy in esophageal cancer (2022 · Cell & Bioscience · 被引 21)
• Augmented reality navigation-guided intraoperative pulmonary nodule localization: a pilot study (2023 · Translational Lung Cancer Research · 被引 12)
• Adjuvant Chemotherapy in pT2N0M0 Gastric Cancer: Findings From a Retrospective Study (2022 · Frontiers in Pharmacology · 被引 12)